反应详情

The title compound was prepared following the procedure of example one with N2-Benzyl-N5-(2-chloro-pyrimidin-4-yl)-1-ethyl-N5-methyl-1H-benzoimidazole-2,5-diamine (98 mg, 0.25 mmol) and 5-amino-2-methyl-benzenesulfonamide (46 mg, 0.25 mmol) as a white solid (83 mg, 58%). 1H NMR (300 MHz, d6-DMSO+NaHCO3) δ 9.54 (s, 1H), 8.56 (s, 1H), 7.80 (d, J=6.3 Hz, 1H), 7.68 (dd, J=8.2 and 1.6 Hz, 1H), 7.15-7.47 (m, 10H), 7.03 (d, J=7.8 Hz, 1H), 5.69 (d, J=6.0 Hz, 1H), 4.68 (d, J=5.7 Hz, 2H), 4.21 (m, 2H), 3.46 (s, 3H), 2.50 (s, 3H), 1.28 (t, J=6.9 Hz, 3H). MS (ESI) m/z=543 [M+H]+.